-+ 0.00%
-+ 0.00%
-+ 0.00%

Acurx Pharmaceuticals Q3 EPS $(0.49) Misses $(0.39) Estimate

Benzinga·11/12/2026 11:55:22
Listen to the news
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.39) by 25.64 percent. This is a 60.16 percent increase over losses of $(1.23) per share from the same period last year.